Solid Dose Manufacturing

INSIGHTS ON SOLID DOSE MANUFACTURING

Layer By Layer: 3D Screen Printing And The Future Of Drug Development
3D screen printing can produce tablets across a range of release profiles, from conventional immediate release tablets to multi-compartment drug delivery systems that mix different release profiles.
Spray Dry Biologics For Oral Dosage Forms
Spray drying enables stable oral delivery of biologics by creating protective dry powders, improving bioavailability, stability, and targeted release compared with traditional formulation methods.
Ask Us Anything: Hannah McLachlan on Crystallization In Peptide Development
Hannah McLachlan, Project Scientist IV at Cambrex Edinburgh, on what crystallization screening delivers for peptide therapeutics — more stable material, higher purity, and a molecule clients can store without specialist infrastructure.
Rational Design And Material-sparing Strategies For Enabled Intermediates And Drug Products
A material-sparing strategy integrating formulation mapping, lab-scale spray drying, and compact screening can accelerate risk identification and inform first-round tablet formulation decisions for poorly soluble APIs.

De-Risking Production Of Complex Oral Solid Dosages: Considerations & Key Capabilities
7/13/2026

Reduce formulation and scale-up risk with integrated development and manufacturing expertise for complex OSD products.
Ask Us Anything: Jillian Sheeran On Emerging Reactor Technologies
7/23/2026

Jillian Sheeran, Associate Director of Engineering at Snapdragon Chemistry, on how automation, feedback control, and machine learning are changing reactor design — with real-time monitoring that lets a process run continuously while the data comes to you.
Precision In Miniature: Optimizing Multiparticulate Formulations For Pediatric Oncology
9/9/2026

When an oral liquid formulation of crizotinib failed pediatric trials due to intolerable taste and irritation, a multiparticulate approach offered a technically demanding but viable path forward.
How To Fast-Track Your Oral Solid Dose To Phase 1
2/17/2026

A strategic approach accelerates oral solid dose development by uniting molecular analysis, solubility improvement, formulation design, manufacturing efficiency, and stability testing to reach Phase 1 faster.
Reducing Uncertainty In Early Oral Drug Development
8/31/2026

Five recurring decision points in early oral solid dose development carry outsized downstream consequences. AI/ML-driven predictive modeling is reframing how teams manage those decisions under API and timeline constraints.

Containment: Bag In Bag Out

The DoverPac® Bag In/Bag Out (BIBO) containment system is a family of contained transfer designs for multiple processes. The primary components for this validated operation consist of multiple groove canisters, docking interface hardware, and softgoods in either continuous liner form or discreet liners.
Pharmaceutical Filling Lines With High Containment

Dec offers pharmaceutical filling lines for both liquids and solids for the aseptic fill-finish process that require high containment equipment.
Small Is Powerful, Small Is Green

As the pharmaceutical industry innovates and evolves, learn more about how Nanoform can play a critical role in empowering your company's journey to net zero.
Open Restricted Access Barrier System (RABS) From Franz Ziel

Open RABS as a housing for aseptic processes, e.g., filling, loading, and unloading of freeze dryers. Product protection is achieved by a barrier (oRABS housing with gloves) between the operator and the product.
Compression Blister Filler

Forming part of 3P innovation’s Discover Range, this early-stage development unit uses two sets of die punches to compress pellets and seal them within a blister strip. Used predominantly for dry powder inhalers (DPIs), the ultra-compact filler fits on your lab benchtop.